...
首页> 外文期刊>The Journal of dermatology >Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis
【24h】

Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis

机译:系统性硬化症患者中抗RNA聚合酶III抗体与硅胶假体的关联

获取原文
获取原文并翻译 | 示例

摘要

Systemic sclerosis (SSc) is believed to be caused by a complex interplay between genetic factors and environmental influences. Although silicone has been considered to be a candidate of environmental agents, clinical data presented so far fail to show a significant association between silicone breast implant (SBI) and the development of SSc. Because we recently experienced two consecutive SSc patients with anti-RNA polymerase III (RNAP III) antibody who underwent SBI, we here investigated the association of SBI history with the development of SSc positive for anti-RNAP III antibody. Among 262 Japanese SSc patients, of note, the frequency of SBI history was significantly higher in the anti-RNAP III antibody group (16.0% [4/25]) than in the anti-topoisomerase I antibody group (0% [0/87], P < 0.005) and in the anticentromere antibody group (1.2% [2/150], P < 0.005). These results suggest that SBI could influence the development of SSc in a certain subset of patients with anti-RNAP III antibody.
机译:据认为,系统性硬化症(SSc)是由遗传因素和环境影响之间复杂的相互作用引起的。尽管有机硅被认为是环境药物的候选者,但迄今为止提供的临床数据未能显示有机硅乳房植入物(SBI)与SSc的发展之间存在显着关联。因为我们最近经历了连续两次接受抗SBI的抗RNA聚合酶III(RNAP III)抗体的SSc患者,所以在这里我们调查了SBI历史与抗RNAP III抗体阳性SSc的发展之间的关系。值得注意的是,在262名日本SSc患者中,抗RNAP III抗体组(16.0%[4/25])的SBI病史频率明显高于抗拓扑异构酶I抗体组(0%[0/87] ],P <0.005)和抗着丝粒抗体组(1.2%[2/150],P <0.005)。这些结果表明,SBI可能会影响具有抗RNAP III抗体的某些患者亚组SSc的发育。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号